The global clinical chemistry analyzer market was valued at $8,965.00 million in 2014 and is poised to grow at a CAGR of 5.52% between 2014and 2019, to reach $11,728.01 million in 2019. Rapid growth in the diagnostics market, increase in the healthcare spending, and increasing incidence in lifestyle disease will drive the growth of the market. Furthermore, increasing awareness for preventative healthcare, increase in aging population, increase in reagent rental agreements and increasing demand for laboratory automation will aid the demand for clinical chemistry analyzer products.